Madhara ya Typhoid ni yapi?

Madhara ya kawaida ni pamoja na: Anaphylaksi, Maumivu ya viungo, Baridi mwilini, Kizunguzungu, Uchovu.

Nani hapaswi kupata Typhoid?

Vikwazo ni pamoja na: Ugonjwa mkali wa papo hapo na homa, Umri chini ya kiwango cha chini kinachopendekezwa, Mshituko mkali baada ya dozi ya awali, Mzio kwa kijenzi cha chanjo, Ugonjwa wa kutokwa na damu.

Typhoid

Inapendekezwa kwa usafiriSehemu ndogoWHO: TYVi

Muhtasari

Chanjo ya typhoid ya sindano ni chanjo ya polysaccharide (Vi capsular polysaccharide) isiyohai inayotoa kinga dhidi ya ugonjwa wa homa ya matumbo (typhoid fever) unaosababishwa na bakteria Salmonella enterica serovar Typhi. Aina kuu ya chanjo inayotumiwa ni Typhim Vi (Sanofi Pasteur). Chanjo mpya ya Vi-conjugate (Typbar-TCV ya Bharat Biotech) pia imepatikana na imeidhinishwa na WHO mwaka 2017. Homa ya matumbo ni tatizo kubwa la afya ya umma katika nchi za Afrika Mashariki. Tanzania, Kenya, na U

Maudhui haya bado hayapatikani kwa lugha yako. Toleo la Kiingereza linaonyeshwa.

Pregnancy: Safe if travel warrants vaccination.

Injectable typhoid ViCPS (Vi polysaccharide) vaccine is an inactivated subunit vaccine and is considered safe during pregnancy when the risk of typhoid fever warrants vaccination.

Limited formal studies in pregnancy, but extensive post-marketing experience with no safety signals.
Preferred over oral Ty21a (live vaccine) during pregnancy.
WHO recommends vaccination for pregnant travelers to highly endemic areas (South Asia in particular).

Maudhui haya bado hayapatikani kwa lugha yako. Toleo la Kiingereza linaonyeshwa.

Breastfeeding: Safe — no restrictions.

Injectable typhoid ViCPS vaccine is inactivated and poses no risk during breastfeeding. No modification to breastfeeding or vaccination schedule is required.

Maudhui haya bado hayapatikani kwa lugha yako. Toleo la Kiingereza linaonyeshwa.

Pediatric use:

Injectable ViCPS: licensed from 2 years of age.
Children <2 years: ViCPS is not effective due to T-cell-independent polysaccharide response immaturity.
Typhoid conjugate vaccine (TCV, e.g., Typbar-TCV): licensed from 6 months — preferred for young children in endemic settings (WHO prequalified).
Single 0.5 mL IM dose. Revaccinate every 2–3 years if continued exposure.

Maudhui haya bado hayapatikani kwa lugha yako. Toleo la Kiingereza linaonyeshwa.

Geriatric use:

No specific age-related concerns. Standard dose and schedule apply.
Immune response may be slightly reduced in elderly adults, but clinically protective levels are typically achieved.
Food and water precautions remain essential regardless of vaccination status.

Madhara

Ya kawaida sana

Maumivu ya kichwa
Maumivu kwenye eneo la sindano

Ya kawaida

Uchovu
Homa
Ugumu kwenye eneo la sindano
Uwekundu kwenye eneo la sindano
Uvimbe kwenye eneo la sindano
Joto kwenye eneo la sindano
Maumivu ya kiungo
Kupoteza hamu ya kula
Kujisikia vibaya
Maumivu ya misuli
Kichefuchefu

Vizuizi

KamiliUmri chini ya kiwango cha chini kinachopendekezwa
KamiliMshituko mkali baada ya dozi ya awali
KamiliMzio kwa kijenzi cha chanjo
TahadhariUgonjwa mkali wa papo hapo na homa
TahadhariUgonjwa wa kutokwa na damu

Ratiba ya chanjo

Hakuna data ya ratiba inayopatikana.

Inalinda dhidi ya

Homa ya Matumbo

Dalili

TailandiInahitajika
MyamaInapendekezwa
MadagaskaInapendekezwa
IndonesiaInapendekezwa
VietnamuInapendekezwa
GuatemalaInapendekezwa
SyriaInapendekezwa
IndiaInapendekezwa
BangladeshiInapendekezwa
NepaliInapendekezwa

Pata chanjo kabla ya safari yako

Unajua chanjo unayohitaji? Vizuri. Hujui? Tuambie tu unaenda wapi — tutapata chanjo zinazofaa na kliniki. Bure, bila masharti.

Maudhui katika ukurasa huu ni kwa madhumuni ya habari na elimu pekee. Hayaundi ushauri wa kitabibu, utambuzi, au mapendekezo ya matibabu. Ikiwa una wasiwasi wa kiafya, wasiliana na mtaalamu wa afya aliyeidhinishwa. Medova si mtoa huduma za matibabu.

Masharti kamili ya matumizi

Muhtasari

Maeneo

Afya na usalama

Zana na rasilimali

Typhoid